Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺激素释放因子治疗相关副作用常见，但严重到足以停药程度罕见。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴受体激动剂临床应疗效性。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗一种类似多巴多巴激动剂，与第一代多巴激动剂不没有麦角林结构。罗匹尼罗非麦角林结构可以说明其与多巴D2受体有较高结合力。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺激素释放因子治疗相关副作用是常见，但严重到足以停药程度是罕见。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴受体激动临床应疗效性。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似多巴多巴激动，与第一代多巴激动不同是没有麦构。罗匹尼罗非麦构可以说明其与多巴D2受体有较高合力。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺素释放因子治的副作用是常见的，但严重到足以停药的程度是罕见的。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴受体剂临床应效性。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似多巴的多巴剂，与第一代多巴剂不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可以说明其与多巴D2受体有较高的结合力。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺激素释放因子治疗相关的副作用是常见的，但严重到足停药的程度是罕见的。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴受体激动剂临床应疗效性。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似多巴的多巴激动剂，与第一代多巴激动剂不同的是没有麦角林结。罗匹尼罗的非麦角林结说明其与多巴D2受体有较高的结合力。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促腺激素释放因子治疗相关副作用是常见，但严重到足以程度是罕见。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴受体激动剂临床应疗。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

匹尼是一种类似多巴多巴激动剂，与第一代多巴激动剂不同是没有麦角林结构。匹尼非麦角林结构可以说明其与多巴D2受体有较高结合力。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺放因子治疗相关的副作用是常见的，但严重到足以停药的程度是罕见的。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价受体动剂临床应疗效性。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似的动剂，与第一动剂不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可以说明其与D2受体有较高的结合力。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺素释放因子治的副作用是常见的，但严重到足以停药的程度是罕见的。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴受体剂临床应效性。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似多巴的多巴剂，与第一代多巴剂不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可以说明其与多巴D2受体有较高的结合力。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺激素释放因子治疗相关副作用常见，但严重到足以停药程度罕见。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴受体激动剂临床应疗效性。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗一种类似多巴多巴激动剂，与第一代多巴激动剂不同有麦角林结构。罗匹尼罗非麦角林结构可以说明其与多巴D2受体有较高结合力。

Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

短期促性腺激素释放因子治疗相关是常见，但严重到足以停药程度是罕见。

OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

评价巴受体激动剂临床应疗效性。

Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

罗匹尼罗是一种类似巴巴激动剂，与第一代巴激动剂不同是没有麦角林结构。罗匹尼罗非麦角林结构可以说明其与巴D2受体有较高结合力。